Emergent Biosolutions EBS Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's common stock, shares authorized (in shares)?
- Emergent Biosolutions (EBS) reported common stock, shares authorized (in shares) of $200M in Q1 2026.
- How has Emergent Biosolutions's common stock, shares authorized (in shares) changed year-over-year?
- Emergent Biosolutions's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $200M to $200M.
- What is the long-term trend for Emergent Biosolutions's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Emergent Biosolutions's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $200M to $200M.